These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10494116)

  • 1. Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study.
    Walter P; Grosse J; Bihr AM; Kramer G; Schulz HU; Schwantes U; Stöhrer M
    Neurourol Urodyn; 1999; 18(5):447-53. PubMed ID: 10494116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
    Madersbacher H; Stöhrer M; Richter R; Giannetti BM; Mürtz G
    Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?
    Menarini M; Del Popolo G; Di Benedetto P; Haselmann J; Bödeker RH; Schwantes U; Madersbacher H;
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):623-32. PubMed ID: 17190372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption pattern of trospium chloride along the human gastrointestinal tract assessed using local enteral administration.
    Schröder S; Jetter A; Zaigler M; Weyhenmeyer R; Krumbiegel G; Wächter W; Fuhr U
    Int J Clin Pharmacol Ther; 2004 Oct; 42(10):543-9. PubMed ID: 15516023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of trospium chloride.
    Doroshyenko O; Jetter A; Odenthal KP; Fuhr U
    Clin Pharmacokinet; 2005; 44(7):701-20. PubMed ID: 15966754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial.
    Stöhrer M; Bauer P; Giannetti BM; Richter R; Burgdörfer H; Mürtz G
    Urol Int; 1991; 47(3):138-43. PubMed ID: 1771701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
    Shvarts PG; Kadykov AS; Shvedkov VV; Timerbaeva SL; Polevaia EV; Mulach AN
    Urologiia; 2009; (5):24-9. PubMed ID: 20213911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trospium chloride: an effective option for medical treatment of bladder overactivity.
    Füsgen I; Hauri D
    Int J Clin Pharmacol Ther; 2000 May; 38(5):223-34. PubMed ID: 10839466
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reiterated intravesical instillation of capsaicin in neurogenic detrusor hyperreflexia: a 5-years experience of 100 instillations].
    de Sèze M; Wiart L; de Sèze MP; Joseph PA; Brochet B; Ferrière JM; Mazaux JM; Barat M
    Ann Readapt Med Phys; 2001 Nov; 44(8):514-24. PubMed ID: 11788114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
    Fröhlich G; Bulitta M; Strösser W
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
    Staskin D; Sand P; Zinner N; Dmochowski R;
    J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trospium chloride in the management of overactive bladder.
    Rovner ES
    Drugs; 2004; 64(21):2433-46. PubMed ID: 15482001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of once-daily trospium chloride 60 mg extended release and twice-daily trospium chloride 20 mg in healthy adults.
    Silver N; Sandage B; Sabounjian L; Schwiderski U; Shipley J; Harnett M
    J Clin Pharmacol; 2010 Feb; 50(2):143-50. PubMed ID: 19948948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trospium chloride for the treatment of detrusor instability in children.
    Lopez Pereira P; Miguelez C; Caffarati J; Estornell F; Anguera A
    J Urol; 2003 Nov; 170(5):1978-81. PubMed ID: 14532838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia.
    Madersbacher H; Stöhrer M; Richter R; Burgdörfer H; Hachen HJ; Mürtz G
    Br J Urol; 1995 Apr; 75(4):452-6. PubMed ID: 7788255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder.
    MacDiarmid SA; Ellsworth PI; Ginsberg DA; Oefelein MG; Sussman DO
    Urology; 2011 Jan; 77(1):24-9. PubMed ID: 20970833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
    J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder.
    Haupt M; Thommes M; Heidenreich A; Breitkreutz J
    J Control Release; 2013 Sep; 170(2):161-6. PubMed ID: 23732944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.